维普中文期刊产品整合服务
17篇 您的检索式:作者名="Salnikov AV"
    题名 作者 年代 出处 被引量
1CD24 controls Src/STAT3 activity in human tumors显示文摘Bretz NP Salnikov AV Perne C 2012Cell Mol Life Sci2012,69,22:1
2Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimentalcarcinomas显示文摘Salnikov AV Bretz NP Perne C 2013Br J Cancer2013,108,7:1
3Hypoxia Induces EMT in Low and Highly Aggressive Pancreatic Tumor Cells but Only Cells with Cancer Stem Cell Characteristics Acquire Pronounced Migratory Potential显示文摘Salnikov AV Liu L Platen M 2012PLoS One2012,7,46:1
4CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-smal cel lung cancer patients显示文摘Salnikov AV Gladkich J Moldenhauer G 0,,04:1
5CD 133 is indicative for a resistance phenotype but does not repre- sent a prognostic marker for survival of non-small cell lung cancer patients显示文摘Salnikov AV Gladkich J Moldenhauer G 2010Inter J Cancer2010,126,4:1
6CD133 isindicative for a resistance phenotype but does not represent aprognostic marker for survival of non-small cell lung cancerpatients显示文摘Salnikov AV Gladkich J Moldenhauer G 2010Int J Cancer2010,126,4:1
7CD 133 is indicative for a resistance phenotype but dose not represent a prognostic marker for survival of non-small cell lung cancer patients 显示文摘Salnikov AV Gladkich J Moldenhauer G 2010Int J Cancer2010,126,4:1
8Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma显示文摘MOLDENHAUER G SALNIKOV AV LTTGAU AV 2012J Natl Cancer Inst2012,104,8:1
9Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter显示文摘Salnikov AV Kusumawidjaja G Rausch V 2009Cancer Lett2009,275,2:1
10Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas显示文摘Salnikov AV Bretz NP Perne C 2013Br J Cancer2013,108,7:1
11Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas显示文摘Salnikov AV Bretz NP Perne C 2013Br J Cancer2013,108,7:1
12Inhibition of car- cinoma cell-derived VEGF reduces inflammatory charac- teristics in xenograft carcinoma显示文摘Salnikov AV Heldin NE Stuhr LB 2006Int J Cancer2006,119,12:1
13Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma显示文摘Moldenhauer G Salnikov AV Lüttgau S 2012J Natl Cancer Inst2012,104,8:1
14CD133 isindicative for a resistance phenotype but does not represent aprognostic marker for survival of non-small cell lung cancerpatients 显示文摘Salnikov AV Gladkich J Moldenhauer G 2010Int J Cancer2010,126,4:1
15Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experi- mental carcinomas 显示文摘Salnikov AV Bretz NP Perne C 2013Br J Cancer2013,108,7:1
16High-dose, short- term, anti-inflammatory treatment with dexamethasone reduces growth and augments the effects of 5-fluorouracil on dimethyl-alpha-henzanthracene-induced mammary tumors in rats显示文摘Stuhr LE Salnikov AV Iversen VV 2006Seand J Clin Lab Invest2006,66,6:1
17Lowering of tumor interstitial fluid pressure specifically augments efficacy of chemotherapy显示文摘Salnikov AV Iversen VV Koisti M 2003FASEB J2003,17,12:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费